Custom service
Peptide Delivery Validation and Optimization Services
Validate and optimize peptide-mediated delivery for an existing construct
Peptide Delivery Validation and Optimization Services supports programmes that validate and optimize peptide-mediated delivery for an existing construct. In a typical engagement we plan the baseline characterization of client constructs route first, confirm compatibility with DoE optimization around the construct, and release validation and optimization report on a 4–8 weeks schedule.
Chemistry is chosen for the molecule, not from a menu. Where the payload tolerates it we keep baseline characterization of client constructs as the primary option and hold DoE optimization around the construct in reserve, so that scale-up never depends on an unproven step.
Constructs that work inconsistently between batches
Moving a working construct to a new cell type
Constructs with no measurable functional endpoint
In-vivo dosing campaigns without a completed in-vitro validation stage
Delivery programmes are released in two layers: chemical (identity, purity, payload loading) and functional (uptake, knockdown or transfection readout in the agreed cell model). Both layers are documented, because a construct that is chemically perfect but functionally silent is a failure.
Service Highlights
- Baseline characterization of client constructs as the default route, with DoE optimization around the construct held as a proven fallback
- Functional endpoint testing worked into the design where the application requires it
- Every delivery construct is validated for uptake or knockdown function, not just characterized chemically
- Analytical confirmation of every intermediate before the final release
- Serum-stability and competitive-serum conditions are part of the standard test matrix
- Validation and optimization report delivered with a complete conjugation or synthesis certificate
How the work runs
Payload & target review
Payload chemistry, target cell and readout are agreed; Peptide Delivery Validation and Optimization Services concept routes are drafted.
Construct design
Peptide ligand, linker and presentation are designed; baseline characterization of client constructs is selected.
Assembly
The construct is assembled and purified chemically, with payload loading quantified.
Functional validation
Uptake or knockdown is measured in the target cell model, with DoE optimization around the construct controls.
Stability & optimization
Serum stability and iteration rounds tune the design to the agreed specification.
Release & hand-off
Validation and optimization report plus the validation report is released with a handling SOP.
Specifications & timeline
- Turnaround
- 4–8 weeks
- Typical scale
- mg-scale construct plus validation report
- Chemistry options
- baseline characterization of client constructs; DoE optimization around the construct; functional endpoint testing
- Deliverable
- Validation and optimization report
- QC package
- Chemical QC plus functional uptake/delivery assay data
- Shipping
- Blue ice, aliquoted, with handling SOP
Related Products
- Recombinant ProteinsGrowth factors, cytokines and antigens produced across E. coli, yeast, insect and mammalian hosts — over 10,000 items on the shelf and ready to move.
- Native ProteinsIsolated directly from natural sources, preserving native post-translational modifications and conformational epitopes that recombinant systems can miss.
- Monoclonal AntibodiesRecombinant and hybridoma clones characterised for Western blot, IHC, immunofluorescence, ELISA and flow cytometry — application data included.
Next step
Tell us the target, we will tell you what is feasible
Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.